Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: Psychiatric Disorders in Child and Adolescent Offspring of Parents with Schizophrenia and Bipolar Disorders.
A clinical trial update describing a study of psychiatric disorders in children and adolescents who have parents with schizophrenia or bipol…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Intensive TMS for Bipolar Depression [NA]
An intensive transcranial magnetic stimulation (TMS) trial for bipolar depression, including treatment-resistant depression, has completed. …
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Medical Comorbidities in Bipolar Disorder
This clinical trial update indicates that a study on medical comorbidities in bipolar disorder is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women
A completed pilot trial evaluating prophylactic management of lamotrigine in pregnant women with bipolar disorder, major depressive disorder…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Safety and Tolerability of Open-Labeled Iloperidone in Adolescents [Phase 4]
This Phase 4 open-label study evaluates the safety and tolerability of iloperidone in adolescents with schizophrenia or bipolar I disorder a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Contingency Management for Problematic Behavior Reduction in the Community [NA]
A completed clinical trial evaluating contingency management to reduce problematic behaviors in community settings among individuals with sc…
-
EMA approval · 2025-02-26EMA Authorised: Aripiprazole Accord (aripiprazole) — Accord Healthcare S.L.U.
The EMA authorised Aripiprazole Accord as a generic aripiprazole product for schizophrenia and bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression). [Phase 3]
Phase 3 trial assessing the long-term safety and tolerability of an investigational drug for depressive episodes in Bipolar I disorder was t…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Biomarkers for Pharmacoresponse in Bipolar Disorder - Coagulation
Karolinska Institutet is updating a clinical trial that investigates coagulation biomarkers as predictors of pharmacoresponse in bipolar dis…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: NMDA Receptor Modulation for the Treatment of Bipolar I Disorder [Phase 2]
A Phase 2 clinical trial evaluating an NMDA receptor modulation approach for treating Bipolar I Disorder is currently recruiting, sponsored …
-
FDA approval · 2025-02-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application from Bionpharma Inc. for aripiprazole (generic), enabling its continued commercialization with the a…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects [NA]
Clinical trial evaluating the EDIT-B blood test in patients with bipolar disorder or major depressive disorder, assessing its impact on heal…
-
CLINICAL_TRIALS research · 2025-02-17Clinical Trial Update: Epigenetic and Neurochemical Correlates of Bipolar Disorder
A clinical trial sponsored by Assiut University is investigating epigenetic and neurochemical correlates of Bipolar Disorder; the study stat…
-
FDA approval · 2025-02-14FDA Approved: ARIPIPRAZOLE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for aripiprazole from Bionpharma Inc., enabling the generic product to be marketed in the United Sta…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients [Phase 3]
This update reports the completion of a Phase 3 clinical trial evaluating the efficacy of lurasidone on cognitive functioning in patients wi…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Ketamine As an Adjunctive Therapy for Major Depression (2) [Phase 3]
A Phase 3 study evaluating ketamine as an adjunctive therapy for major depressive disorder has completed.
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Efficacy and Safety of Task-activated rTMS in Improving Cognitive Function in Patients With Bipolar Disorder [NA]
A clinical trial is evaluating the efficacy and safety of task-activated repetitive transcranial magnetic stimulation to improve cognitive f…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: MonPsy&Moi: A Digital Platform for Collecting Patient-Reported Experience and Outcome Measures in Psychiatry
Clinical trial update describing MonPsy&Moi, a digital platform to collect patient-reported experiences and outcomes in psychiatry, sponsore…
-
CLINICAL_TRIALS trial_result · 2025-02-07Clinical Trial Update: Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response, Pilot Trial [Phase 1]
This update reports the completion of a Phase 1 pilot trial investigating AMPA receptor components in the antidepressant response to ketamin…
-
CLINICAL_TRIALS trial_result · 2025-02-06Clinical Trial Update: Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression [NA]
A completed clinical trial update investigating neural correlates of ketamine's anti-suicidal effects in bipolar depression.
-
CLINICAL_TRIALS research · 2025-02-06Clinical Trial Update: Healthy Lifestyles for Bipolar Disorder [NA]
A UC Berkeley-led clinical trial is evaluating whether time-restricted eating and Mediterranean-style diet interventions can benefit individ…
-
CLINICAL_TRIALS trial_result · 2025-02-04Clinical Trial Update: RTMS Feasibility Study on Adolescent Depression Stimulation [NA]
A completed feasibility study evaluating repetitive transcranial magnetic stimulation (RTMS) for adolescent depression.
-
FDA approval · 2025-01-29FDA Approved: OLANZAPINE AND FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva Pharmaceuticals' generic olanzapine and fluoxetine combination product.
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: Effects of Low Dose Aspirin in Bipolar Disorder (The A-Bipolar RCT) [Phase 2]
Phase 2 randomized trial evaluating low-dose aspirin for bipolar disorder has completed. The update notes the study status as COMPLETED, but…
-
CLINICAL_TRIALS trial_result · 2025-01-29Clinical Trial Update: A Register Study of Effects Following Local Variation in Rates of Involuntary Care
A register study assessing outcomes after local variation in involuntary care rates among people with schizophrenia and bipolar disorder; th…